Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review
Background: Patients with cancer-associated thrombosis (CAT) are at an increased risk of recurrent thrombosis and bleeding, especially if there is treatment- or disease-related thrombocytopenia. While direct oral anticoagulants (DOACs) are used in the management of CAT, low molecular weight heparin...
Saved in:
Main Authors: | Umaima Abbas, Robin MacKenzie, Ushra Khan, Rija Fatima, Tzu-Fei Wang, Rong Luo, Caroline Hamm, Andrea Cervi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925000081 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01) -
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
by: Kai Chin Poh, et al.
Published: (2022-07-01) -
Thrombosis with thrombocytopenia after first dose of ChAdOx1 nCoV-19 vaccine: a case report
by: K. Kolodynskaja, et al.
Published: (2021-12-01) -
A case report of deep vein thrombosis after cardiac surgery for left atrial myxoma
by: Hong Wang, et al.
Published: (2025-02-01) -
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?
by: Ravi Patel, et al.
Published: (2025-01-01)